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an increasing funding shortfall. Novel strategies include commu-
nity models of care, for testing, adherence support and delivery of
ART.
AIDS is far from over as challenges ahead dwarf the impressive
achievements of ART scale up to date. Yet treatment as prevention
is already showing early signs of success...
http://dx.doi.org/10.1016/j.ijid.2014.03.479
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Background: Pregnant women and young infants are at
increased risk for severe inﬂuenza-illness. Inﬂuenza vaccination
duringpregnancymay confer indirect protection against inﬂuenza-
illness to infants <6 months of age, for whom there is no licensed
inﬂuenza vaccine. A co-primary objective of our study was to eval-
uate the efﬁcacy of trivalent inactivated inﬂuenza vaccine (IIV3)
when given during pregnancy against PCR-conﬁrmed inﬂuenza-
illness (PCI) in their infants up until 6 months of age.
Methods & Materials: We conducted a double-blind, random-
ized, placebo-controlled trial in Soweto, South Africa during the
2011 and 2012 inﬂuenza seasons. 2116 HIV-uninfected women
were randomized to receive IIV3 or placebo intramuscularly
between 20-36 weeks gestation. Infants were screened weekly
for inﬂuenza-like-illness (ILI) after birth. When ILI was suspected
nasopharyngeal aspirates were collected for inﬂuenza A and B
testing by real-time PCR. Inﬂuenza A viruses were subtyped for
A/H1N1pdm09 and H3N2 and inﬂuenza B isolates were tested for
Yamagata and Victoria lineages.
Results:Pregnancyoutcomeswere similar between the IIV3and
placebo-group, including 8 miscarriages and 22 stillbirths. 2048
babies were born alive, 1025 and 1023 to mothers who received
IIV3 andplacebo, respectively. The rates of pretermdeliveries (10%)
and low birth weight (12.4%) were also similar between the study
groups. 706 and 698 illness visits were completed in infants of
mothers who received IIV3 and placebo, respectively; of which
665 (64.9%) and 656 (64.1%) illness episodes fulﬁlled ILI crite-
ria. In infants born to IIV3-recipients, 19 PCI cases were detected
compared to 37 in infants born to placebo-recipients, resulting
in vaccine efﬁcacy of 48.8% (95%CI: 11.5% to 70.3%) against PCI
in infants. Excluding the non-vaccine inﬂuenza B/Yamagata cases
from the analysis vaccine efﬁcacy (VE) did not change (VE: 48.1%;
95%CI: -0.9% to 73.3%). In twelve (21.4%) of the 56 PCI cases among
infants (including 11 whose mothers received placebo), PCI was
also identiﬁed concurrently in the mother.
Conclusion: Vaccination of African pregnant women with IIV3
was safe and reduced PCI in their infants by 49% up until 6 months
of age. Immunization of pregnant women with IIV3 is warranted
for the protection of their young infants.
http://dx.doi.org/10.1016/j.ijid.2014.03.480
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Clinical and epidemiologic characteristics of
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Background: Acute respiratory infections (ARIs) are a major
cause ofmorbidity andmortality among childrenworldwide. How-
ever, information about viral etiologies ofARIs fromdeveloping and
tropical countries is limited. Understanding the etiologies of ARIs
in hospitalized children is essential for improving prevention, diag-
nosis and treatment in these settings. This study was conducted to
describe the clinical and epidemiologic characteristics of viral ARIs
in hospitalized children in Vietnam.
Methods & Materials: From April 2010 to May 2011, clinical
data and nasopharyngeal (NP) samples were collected from chil-
dren with ARIs admitted to Children’s Hospital 2 at Ho Chi Minh
City, Vietnam. Four multiplex PCR assays were performed to detect
13 respiratory viruses in NP samples.
Results: A total of 1,082 were enrolled. At least one pathogen
wasdetected in 64%of caseswith 9.1%were co-infections. Themost
frequent pathogens were rhinovirus (RV) (30%), respiratory syncy-
tial virus (RSV) (23.8%), human bocavirus (HBoV) (7.2%) followed
by parainﬂuenzae virus (PIV) type 3 (5.3%), PIV type 1 (3.3%), and
inﬂuenzaA (FluA) (3.2%). RV infectionoccurredall year round,while
RSV epidemic occurred mainly in the rainy season. FluA infections
peaked in both seasonswith seasonal H3N2 in the rainy season and
pandemic H1N1 2009 in the dry season. Other viruses were pre-
dominant in thedry season.RV infectionsoccurred inall agegroups.
RSV, PIV3, PIV1 and HBoV, FluA caused infections predominantly
in children<6 months, 6 – 12 months, 12 – 24 months, and>24
months, respectively. Signiﬁcant associations were found between
PIV1 with croup (p<0.005) and RSV with bronchiolitis (p <0.005).
HBoVandRV infectionswere associatedwithhypoxia (p <0.05) and
RSV infectionswith lower chest indrawing (p<0.05). RSV subgroup
A had severity score higher than subgroup B (p<0.05). Pandemic
H1N1 2009 and co-infections did not lead to more severe symp-
toms.
Conclusion: A high incidence of virus-associated ARIs, in which
RV, RSV and HBoV were the leading causes, was found among hos-
